title: A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection.
abstract: The purpose of this study was to develop and characterize a rat model of choroidal neovascularization (CNV) as occurs in age-related macular degeneration. The lipid hydroperoxide 13(S)-hydroperoxy-9Z,11E-octadecadienoic acid (HpODE) is found in submacular Bruch's membrane in aged humans and has been reported to generate neovascularization in a rabbit model. Three weeks after a single subretinal injection of 30 microg of HpODE, eyes of Sprague-Dawley rats were harvested. Follow-up fluorescein angiography was done on other animals until 5 weeks postinjection. Histological studies, immunohistochemical staining, and flatmount choroids for CNV measurements were performed. In addition, we used murine neuronal, bovine endothelial, and human ARPE19 cells for testing the in vitro effects of HpODE. CNV developed in 85.7% of HpODE-injected eyes. The neovascular areas were significantly greater in HpODE-injected eyes compared with those in control eyes (P = 0.023). The CNV had maximum dye leakage at 3 weeks, which subsided by the 5th week. Histologically, CNV extended from the choriocapillaris into the subretinal space. ED1-positive macrophages were recruited to the site. In vitro assays demonstrated that only 30 ng/ml HpODE induced cell proliferation and migration of endothelial cells. HpODE-induced CNV was highly reproducible, and its natural course seems to be ideal for evaluating therapeutic modalities. Because HpODE has been isolated from aged humans, the HpODE-induced rat model seems to be a relevant experimental model for CNV in age-related macular degeneration.
authors.affiliation: Wilmer Ophthalmological Institute, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21287, USA.
authors.forename: Takayuki
authors.initials: T
authors.lastname: Baba
authors.forename: Imran A
authors.initials: IA
authors.lastname: Bhutto
authors.forename: Carol
authors.initials: C
authors.lastname: Merges
authors.forename: Rhonda
authors.initials: R
authors.lastname: Grebe
authors.forename: David
authors.initials: D
authors.lastname: Emmert
authors.forename: D Scott
authors.initials: DS
authors.lastname: McLeod
authors.forename: Donald
authors.initials: D
authors.lastname: Armstrong
authors.forename: Gerard A
authors.initials: GA
authors.lastname: Lutty
mesh_terms: D000818:Animals; D002417:Cattle; D002460:Cell Line; D049109:Cell Proliferation; D002829:Choroid / Q000473:pathology / Q000648:ultrastructure; D020256:Choroidal Neovascularization / Q000139:chemically induced* / Q000473:pathology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007267:Injections; D008054:Lipid Peroxides / Q000009:adverse effects*; D008268:Macular Degeneration / Q000473:pathology*; D008297:Male; D051379:Mice; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D012160:Retina / Q000473:pathology / Q000648:ultrastructure
chemical_list: D008054:Lipid Peroxides
references.citation: Exp Eye Res. 2002 Feb;74(2):301-8
references.pmid: 11950240
references.citation: Science. 2005 Apr 15;308(5720):419-21
references.pmid: 15761120
references.citation: Retina. 1999;19(2):141-7
references.pmid: 10213241
references.citation: Jpn J Ophthalmol. 1997 Sep-Oct;41(5):284-96
references.pmid: 9363556
references.citation: Invest Ophthalmol Vis Sci. 1994 Jul;35(8):3234-50
references.pmid: 8045716
references.citation: Invest Ophthalmol Vis Sci. 1987 Jul;28(7):1116-30
references.pmid: 2439474
references.citation: Immunology. 1985 Mar;54(3):589-99
references.pmid: 3882559
references.citation: Invest Ophthalmol Vis Sci. 1999 Aug;40(9):1891-8
references.pmid: 10440240
references.citation: Invest Ophthalmol Vis Sci. 2004 May;45(5):1544-52
references.pmid: 15111613
references.citation: Mol Vis. 2002 Apr 21;8:119-26
references.pmid: 11979237
references.citation: Exp Eye Res. 2003 Apr;76(4):463-71
references.pmid: 12634111
references.citation: Br J Ophthalmol. 1976 May;60(5):324-41
references.pmid: 952802
references.citation: Ophthalmology. 1993 Oct;100(10):1519-35
references.pmid: 7692366
references.citation: Invest Ophthalmol Vis Sci. 2009 Feb;50(2):870-7
references.pmid: 18806290
references.citation: Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32
references.pmid: 15870199
references.citation: Science. 2005 Apr 15;308(5720):385-9
references.pmid: 15761122
references.citation: Exp Eye Res. 1982 Aug;35(2):157-71
references.pmid: 7151884
references.citation: Angiogenesis. 1998;2(1):93-104
references.pmid: 14517379
references.citation: Annu Rev Biochem. 1998;67:395-424
references.pmid: 9759493
references.citation: Exp Eye Res. 2005 Mar;80(3):369-78
references.pmid: 15721619
references.citation: Exp Eye Res. 2005 Aug;81(2):193-9
references.pmid: 16080913
references.citation: Invest Ophthalmol Vis Sci. 1993 Mar;34(3):477-87
references.pmid: 7680639
references.citation: Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3578-85
references.pmid: 12882810
references.citation: Am J Pathol. 2006 Feb;168(2):639-48
references.pmid: 16436677
references.citation: J Leukoc Biol. 2003 Jul;74(1):25-32
references.pmid: 12832439
references.citation: J Neurochem. 2008 May;105(4):1187-97
references.pmid: 18182060
references.citation: Am J Pathol. 2003 Feb;162(2):413-25
references.pmid: 12547700
references.citation: Trans Am Ophthalmol Soc. 1996;94:411-30; discussion 430-1
references.pmid: 8981707
references.citation: Prog Retin Eye Res. 2009 Nov;28(6):393-422
references.pmid: 19698799
references.citation: Graefes Arch Clin Exp Ophthalmol. 1997 May;235(5):313-9
references.pmid: 9176680
references.citation: Trans Am Ophthalmol Soc. 1979;77:707-45
references.pmid: 94717
references.citation: Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1236-49
references.pmid: 8641827
references.citation: Curr Eye Res. 2006 Apr;31(4):337-46
references.pmid: 16603467
references.citation: Science. 2005 Apr 15;308(5720):421-4
references.pmid: 15761121
references.citation: Exp Eye Res. 2006 Jan;82(1):99-110
references.pmid: 16019000
references.citation: Mol Vis. 2005 Jun 16;11:414-24
references.pmid: 15988410
references.citation: J Leukoc Biol. 1989 Dec;46(6):556-64
references.pmid: 2572659
references.citation: Free Radic Biol Med. 1991;11(1):81-128
references.pmid: 1937131
references.citation: Br J Ophthalmol. 2004 Sep;88(9):1217-22
references.pmid: 15317719
references.citation: Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1801-7
references.pmid: 17389514
references.citation: Invest Ophthalmol. 1976 Jun;15(6):443-6
references.pmid: 931687
references.citation: Surv Ophthalmol. 2006 Mar-Apr;51(2):137-52
references.pmid: 16500214
references.citation: Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5163-70
references.pmid: 17122098
references.citation: Surv Ophthalmol. 2003 May-Jun;48(3):257-93
references.pmid: 12745003
references.citation: Mol Vis. 2007 May 23;13:772-8
references.pmid: 17563727